NDC 61958-3001

Sunlenca

Lenacapavir Sodium

Sunlenca is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences. The primary component is Lenacapavir Sodium.

• Product ID: 61958-3001_e2f725c8-d250-42e1-bb62-249cf99bcb28
• NDC: 61958-3001
• Product Type: Human Prescription Drug
• Proprietary Name: Sunlenca
• Generic Name: Lenacapavir Sodium
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2022-12-22
• Marketing Category: NDA /
• Application Number: NDA215974
• Labeler Name: Gilead Sciences
• Substance Name: LENACAPAVIR SODIUM
• Active Ingredient Strength: 300 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2024-12-31

Packaging

NDC 61958-3001-1

1 POUCH in 1 CARTON (61958-3001-1) > 1 BLISTER PACK in 1 POUCH > 4 TABLET, FILM COATED in 1 BLISTER PACK

• Marketing Start Date: 2022-12-22
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Sunlenca" or generic name "Lenacapavir Sodium"

NDC	Brand Name	Generic Name
61958-3001	Sunlenca	LENACAPAVIR SODIUM
61958-3002	Sunlenca	LENACAPAVIR SODIUM